Nuveen »

Eliem Therapeutics shares owned by Nuveen

Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by Nuveen from 13F filings

Historical chart of Nuveen investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by Nuveen consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by Nuveen

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.1M 86k 13.04
2025-03-31 $48k 39k 1.22

More positions owned by Nuveen

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Micron Technology (MU)
Applied Materials (AMAT)
Lam Research Corp Com New (LRCX)
Advanced Micro Devices (AMD)

View all positions for Nuveen

Top funds holding Eliem Therapeutics

RA Capital Management
FMR
UBS Group
Braidwell
Adage Capital Partners GP
BlackRock
Cormorant Asset Management
Frontier Capital Management
T. Rowe Price Associates
Vanguard Capital Management
Woodline Partners
Citadel Advisors
Redmile Group
Dr. Jeffrey R. Jay, M.D.
Affinity Asset Advisors

View all funds holding Eliem Therapeutics